title: Biomarkers and imaging in non-malignant and malignant osteomalacia.
abstract: Deoxypyridinium (DPD) cross-links are a specific parameter for collagen type I degradation. We report the longitudinal tracking of DPD in relation to other bone markers and imaging techniques in a patient with osteomalacia and secondary hyperparathyroidism from reduced light exposure due to attire. This patient was first admitted for diffuse skeletal pain. X-rays showed general demineralization and Looser's transformation zones in the neck of the left femur. MRI examinations of the pelvis and the proximal femora demonstrated bilateral signs of acute sacroiliitis, as well as edema-like lesions in the femoral heads and necks bilaterally. The baseline parathyroid hormone level was 8 times higher than the normal upper limit, whereas 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels were significantly reduced. A 7-fold increase in free urinary DPD and a 17-fold increase in bone-specific alkaline phosphatase (bone-AP) were also measured. Percutaneous transiliac bone biopsy revealed markedly increased osteoidosis. Osteomalacia was diagnosed due to chronically reduced sun exposure caused by restrictive attire, and cholecalciferol substitution therapy was begun. After a follow-up of 28 weeks, non-specific parameters of bone turnover (parathyroid hormone, total alkaline phosphatase, serum calcium and serum phosphate) had normalized, while DPD, as a specific bone degradation marker, and bone-AP, as a bone formation parameter, both remained elevated. This example underlines the validity of DPD and bone-AP as indicators of increased bone metabolism: not only were they the parameters with the highest baseline deviation, but they were also the last to normalize.
authors.affiliation: Medizinische Klinik und Poliklinik II, Schwerpunkt Onkologie und Hämatologie, Universitatsklinikum Charité, Humboldt-Universität, Berlin, Germany. Diana.Lueftner@rz.hu-berlin.de
authors.forename: D
authors.initials: D
authors.lastname: Lüftner
authors.forename: M
authors.initials: M
authors.lastname: Bollow
authors.forename: A
authors.initials: A
authors.lastname: Stürzenbecher
authors.lastname: Kaufmann
authors.forename: F
authors.initials: F
authors.lastname: Priem
authors.forename: A
authors.initials: A
authors.lastname: Richter
authors.forename: S
authors.initials: S
authors.lastname: Gunther
authors.forename: R
authors.initials: R
authors.lastname: Geppert
authors.forename: P E
authors.initials: PE
authors.lastname: Petrides
authors.forename: K D
authors.initials: KD
authors.lastname: Wernecke
authors.forename: K
authors.initials: K
authors.lastname: Possinger
mesh_terms: D000293:Adolescent; D015415:Biomarkers / Q000652:urine*; D001842:Bone and Bones / Q000000981:diagnostic imaging; D002117:Calcitriol / Q000097:blood; D005260:Female; D006801:Humans; D006961:Hyperparathyroidism / Q000150:complications / Q000000981:diagnostic imaging / Q000652:urine*; D010018:Osteomalacia / Q000000981:diagnostic imaging / Q000209:etiology / Q000652:urine*; D010281:Parathyroid Hormone / Q000097:blood; D010710:Phosphates / Q000097:blood; D011726:Pyridinium Compounds / Q000652:urine*; D011859:Radiography
chemical_list: D015415:Biomarkers; D010281:Parathyroid Hormone; D010710:Phosphates; D011726:Pyridinium Compounds; D002117:Calcitriol